JP2005524663A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005524663A5 JP2005524663A5 JP2003572516A JP2003572516A JP2005524663A5 JP 2005524663 A5 JP2005524663 A5 JP 2005524663A5 JP 2003572516 A JP2003572516 A JP 2003572516A JP 2003572516 A JP2003572516 A JP 2003572516A JP 2005524663 A5 JP2005524663 A5 JP 2005524663A5
- Authority
- JP
- Japan
- Prior art keywords
- syndrome
- injection
- nerve
- agent according
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010874 syndrome Diseases 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 238000002347 injection Methods 0.000 claims 4
- 239000007924 injection Substances 0.000 claims 4
- 108010043024 Botulinum Toxins Proteins 0.000 claims 2
- 229940053031 botulinum toxin Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000003295 Carpal Tunnel Syndrome Diseases 0.000 claims 1
- 210000002808 Connective Tissue Anatomy 0.000 claims 1
- 210000001513 Elbow Anatomy 0.000 claims 1
- 210000003205 Muscles Anatomy 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000008713 Piriformis Muscle Syndrome Diseases 0.000 claims 1
- 206010049433 Piriformis syndrome Diseases 0.000 claims 1
- 231100000765 Toxin Toxicity 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
Claims (7)
- 処置を必要とする患者の神経エントラップメント症候群を処置するための、治療に有効量のB型ボツリヌス毒素を含む処置剤。
- 処置を必要とする患者の神経エントラップメント症候群による痛みを減らすための、治療に有効量のB型ボツリヌス毒素を含む処置剤。
- 毒素が、針を通じた注射により投与される、請求項1または2に記載の処置剤。
- 神経エントラップメント症候群が、梨状筋症候群、手根管症候群、肘部管症候群、および橈骨管症候群からなる群より選択される、請求項1または2に記載の処置剤。
- 注射が、圧迫された神経に接する筋組織に対して行われる、請求項3に記載の処置剤。
- 注射が、圧迫された神経のまわりの間質領域に対して行われる、請求項3に記載の処置剤。
- 注射が、圧迫された神経を囲む結合組織に対して行われる、請求項3に記載の処置剤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36062802P | 2002-03-01 | 2002-03-01 | |
PCT/US2003/006233 WO2003073994A2 (en) | 2002-03-01 | 2003-02-27 | Methods of treating nerve entrapment syndromes |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005524663A JP2005524663A (ja) | 2005-08-18 |
JP2005524663A5 true JP2005524663A5 (ja) | 2006-04-13 |
Family
ID=27788996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003572516A Pending JP2005524663A (ja) | 2002-03-01 | 2003-02-27 | 神経エントラップメント症候群の処置方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20030224019A1 (ja) |
EP (1) | EP1487481A4 (ja) |
JP (1) | JP2005524663A (ja) |
KR (1) | KR20040094756A (ja) |
AU (2) | AU2003212473A1 (ja) |
CA (1) | CA2477808A1 (ja) |
WO (1) | WO2003073994A2 (ja) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7838008B2 (en) | 1999-12-07 | 2010-11-23 | Allergan, Inc. | Methods for treating diverse cancers |
EP1487481A4 (en) * | 2002-03-01 | 2005-11-23 | Elan Pharm Inc | METHOD FOR TREATING NERVE TERMINATION SYNDROMES |
US7300412B2 (en) * | 2002-05-10 | 2007-11-27 | Hospital For Joint Diseases | Methods for therapeutic treatment of carpal tunnel syndrome |
US8734810B2 (en) * | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
US8871224B2 (en) * | 2003-12-09 | 2014-10-28 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
US20100266638A1 (en) | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
US20050191321A1 (en) * | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
US9078892B2 (en) * | 2004-02-26 | 2015-07-14 | Allergan, Inc. | Methods for treating pain and for treating a medication overuse disorder |
US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
US20050220734A1 (en) * | 2004-04-02 | 2005-10-06 | Allergan, Inc. | Therapy for melanin related afflictions |
KR100668570B1 (ko) * | 2004-06-28 | 2007-01-16 | 입센 리미티드 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
US6991789B2 (en) * | 2004-06-29 | 2006-01-31 | Allergas, Inc. | Methods of modulating intracellular degradation rates of toxins |
US20060024331A1 (en) * | 2004-08-02 | 2006-02-02 | Ester Fernandez-Salas | Toxin compounds with enhanced membrane translocation characteristics |
US7429386B2 (en) * | 2004-09-03 | 2008-09-30 | Allergan, Inc. | Stretch mark treatment |
US7179474B2 (en) * | 2004-09-03 | 2007-02-20 | Allergan, Inc. | Methods for treating a buttock deformity |
US7897147B2 (en) | 2004-10-20 | 2011-03-01 | Allergan, Inc. | Treatment of premenstrual disorders |
US7749515B2 (en) | 2005-02-01 | 2010-07-06 | Allergan, Inc. | Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
US7655244B2 (en) | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
US7419675B2 (en) * | 2005-05-26 | 2008-09-02 | Allergan, Inc. | Method for treating peritoneal adhesions |
US7824694B2 (en) * | 2006-01-12 | 2010-11-02 | Allergan, Inc. | Methods for enhancing therapeutic effects of a neurotoxin |
US20070178121A1 (en) * | 2006-01-27 | 2007-08-02 | Allergan, Inc. | Methods for enhancing skin treatments |
CN101074935B (zh) * | 2006-05-19 | 2011-03-23 | 清华大学 | 探测器阵列及设备 |
US9061025B2 (en) * | 2006-08-31 | 2015-06-23 | Allergan, Inc. | Methods for selecting headache patients responsive to botulinum toxin therapy |
US8617571B2 (en) | 2008-04-03 | 2013-12-31 | Allergan, Inc. | Suture line administration technique using botulinum toxin |
US20100028385A1 (en) * | 2008-08-04 | 2010-02-04 | Allergan, Inc. | Treatment of excess cerumen secretion |
CA2774951C (en) | 2009-09-24 | 2014-12-16 | Allergan, Inc. | Method of treating osteoporosis with a neurotoxin |
US9238324B2 (en) | 2010-03-31 | 2016-01-19 | Toray Plastics (Amercia), Inc. | Biaxially oriented polylactic acid film with reduced noise level |
US9782617B2 (en) | 2010-09-19 | 2017-10-10 | Thomas Alan Ferguson, JR. | Piri-stretcher system |
US9101794B2 (en) | 2010-09-19 | 2015-08-11 | Thomas Alan Ferguson, JR. | Piri-stretcher |
US8697090B2 (en) | 2011-05-05 | 2014-04-15 | Allergan, Inc. | Method of treating persistent genital arousal disorder with a neurotoxin |
EP2649985A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
EP2649983A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (II) |
BR112014025396B1 (pt) | 2012-04-13 | 2020-03-17 | Lubrizol Advanced Materials, Inc. | Composto, composição cosmética ou farmacêutica, e, uso de um composto |
EP2649984A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
WO2018038301A1 (en) | 2016-08-26 | 2018-03-01 | Hugel Inc. | Stabilized liquid formulation of botulinum toxin and preparation method thereof |
EP3470054B1 (en) | 2017-10-11 | 2023-09-20 | Hugel Inc. | Microstructure formulation techniques for botulinum toxin |
US10525111B2 (en) | 2017-10-12 | 2020-01-07 | Hugel, Inc. | Microstructure formulation techniques for botulinum toxin |
US10792400B2 (en) | 2017-10-12 | 2020-10-06 | Hugel Inc. | Microstructure formulation techniques for botulinum toxin |
US10561715B2 (en) * | 2018-02-26 | 2020-02-18 | Philip Andrew RADOVIC | Plantar heel pain syndrome treatment |
EP3660509B1 (en) | 2018-11-29 | 2022-03-09 | Hugel Inc. | A cell-based method for determining an activity of botulinum toxin |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4932936A (en) * | 1988-01-29 | 1990-06-12 | Regents Of The University Of Minnesota | Method and device for pharmacological control of spasticity |
US5053005A (en) * | 1989-04-21 | 1991-10-01 | Gary E. Borodic | Chemomodulation of curvature of the juvenile spine |
US5183462A (en) * | 1990-08-21 | 1993-02-02 | Associated Synapse Biologics | Controlled administration of chemodenervating pharmaceuticals |
WO1994000481A1 (en) * | 1992-06-23 | 1994-01-06 | Associated Synapse Biologics | Pharmaceutical composition containing botulinum b complex |
US5437291A (en) * | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
US5766605A (en) * | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
EP0758900B1 (en) * | 1994-05-09 | 2002-04-10 | BINDER, William J. | Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
US5512547A (en) * | 1994-10-13 | 1996-04-30 | Wisconsin Alumni Research Foundation | Pharmaceutical composition of botulinum neurotoxin and method of preparation |
US5562899A (en) * | 1995-02-28 | 1996-10-08 | Gerber; Allen | Medical prevention of lacerations to the vagina and perineum |
US5721215A (en) * | 1996-03-20 | 1998-02-24 | Allergan | Injectable therapy for control of muscle spasms and pain related to muscle spasms |
US6063768A (en) * | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
US6113915A (en) * | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
US6139845A (en) * | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US6358513B1 (en) * | 2000-02-15 | 2002-03-19 | Allergan Sales, Inc. | Method for treating Hashimoto's thyroiditis |
CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
EP1487481A4 (en) * | 2002-03-01 | 2005-11-23 | Elan Pharm Inc | METHOD FOR TREATING NERVE TERMINATION SYNDROMES |
-
2003
- 2003-02-27 EP EP03709413A patent/EP1487481A4/en not_active Withdrawn
- 2003-02-27 JP JP2003572516A patent/JP2005524663A/ja active Pending
- 2003-02-27 AU AU2003212473A patent/AU2003212473A1/en not_active Abandoned
- 2003-02-27 WO PCT/US2003/006233 patent/WO2003073994A2/en active Application Filing
- 2003-02-27 KR KR10-2004-7013635A patent/KR20040094756A/ko not_active Application Discontinuation
- 2003-02-27 US US10/378,042 patent/US20030224019A1/en not_active Abandoned
- 2003-02-27 CA CA002477808A patent/CA2477808A1/en not_active Abandoned
-
2008
- 2008-03-26 US US12/056,096 patent/US20080171065A1/en not_active Abandoned
-
2009
- 2009-05-01 AU AU2009201770A patent/AU2009201770A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005524663A5 (ja) | ||
MX337511B (es) | Medicamentos y metodos para tratar cefaleas. | |
JP2006501240A5 (ja) | ||
IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
JP2007514749A5 (ja) | ||
EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
CA2549550A1 (en) | Botulinum toxin therapy for skin disorders | |
DK2145629T3 (da) | Anvendelse af neurotoksinterapi til behandling af urologiske og relaterede sygdomme | |
JP2002532432A5 (ja) | ||
NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
Koo et al. | Antiemetic efficacy of capsicum plaster on acupuncture points in patients undergoing thyroid operation | |
EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
JP2003528919A5 (ja) | ||
RU2002129355A (ru) | Применение фульвестранта при лечении резистентного рака молочной железы | |
JP2005507888A5 (ja) | ||
RU2002103808A (ru) | Способ лечения болевого синдрома у онкологических больных | |
WO2003103699A8 (en) | USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS | |
CA2561588A1 (en) | Pressure sore treatment | |
DE60216292D1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
ATE247965T1 (de) | Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung | |
CA2521177A1 (en) | Use of a botulinum neurotoxin to alleviate various disorders | |
ATE411342T1 (de) | Scfv antikörper gegen krankheiten-assoziierte moleküle |